Parliamentary Panel Not Yet Ready To Recommend India’s CDA Bill
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - A parliamentary committee examining the bills to set up a central drug authority in India is not yet set to give its recommendations, which would pave the way for the bills to be debated and passed in the parliament. The CDA bill has been approved by the country's Cabinet of Ministers and is currently with the parliamentary panel
You may also be interested in...
India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted
Disseminated power appears to be the goal, but would the system require four times the paperwork?
India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted
Disseminated power appears to be the goal, but would the system require four times the paperwork?
India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted
MUMBAI - Efforts to streamline India's drug regulatory system into a single central authority may suffer a body blow as the parliamentary committee set up to study the proposed changes may recommend scrapping the new body. Top industry sources told PharmAsia News that the committee is not completely convinced about the advantages of having a Central Drug Authority